Category: Biotech stock doubles in single day after treatment for a rare lung disease has successful trial

Biotech stock doubles in single day after treatment for a rare lung disease has successful trial

  1. Biotech stock doubles in single day after treatment for a rare lung disease has successful trial  CNBC
  2. Insmed soars on strong results for inhaled antibiotic  BioPharma Dive
  3. Insmed Inc. (INSM) Has Surged To A New High On Phase 3 Study Results  Nasdaq
  4. Full coverage

from Business – Google News https://www.cnbc.com/2017/09/05/biotech-stock-doubles-treatment-for-a-rare-lung-disease-has-successful-trial.html

Advertisements